Literature DB >> 15729833

Determination of haemoglobin adducts of acrylamide and glycidamide in smoking and non-smoking persons of the general population.

Thomas Schettgen1, Bernd Rossbach, Birgitta Kütting, Stefan Letzel, Hans Drexler, Jürgen Angerer.   

Abstract

Acrylamide (AA) is a food-borne toxicant suspected to be carcinogenic to humans. It is formed in the heating process of starch-containing food. Currently, there is a great discussion about the possible human health risks connected with the dietary uptake of acrylamide. Haemoglobin adducts of acrylamide and its oxidative metabolite glycidamide are both markers of biochemical effect. However, because glycidamide has a higher carcinogenic potency than acrylamide itself, the glycidamide adduct might mirror the genotoxicity better than acrylamide adducts. In order to gain more information about the human metabolism of acrylamide, we investigated a small group of persons for the effective internal doses of acrylamide and glycidamide using haemoglobin adducts as parameters of biochemical effect. The collective was subdivided into non-smokers (n=13) and smokers (n=16) by determining the smoking-specific acrylonitrile haemoglobin adduct (N-cyanoethylvaline, CEV). The mean values for the adducts of acrylamide (N-2-carbamoylethylvaline, AAVal) and glycidamide (N-(R,S)-2-hydroxy-2-carbamoylethylvaline, GAVal) in nonsmokers was 19 pmol/g globin AAVal (range 7-31 pmol/g globin) and 17 pmol/g globin GAVal (range 9-23 pmol/g globin). For smokers mean levels of AAVal were 80 pmol/g globin (range: 25-199 pmol/g globin) and those of GAVal were 53 pmol/g globin (range: 22-119 pmol/g globin). Metabolism to glycidamide turned out to be significantly more effective in non-smokers than in the higher exposed smokers. Compared with studies in rats, the metabolic conversion of acrylamide to glycidamide as measured by haemoglobin adducts seems to occur to a similar extent in humans as in rats. Risk estimations on acrylamide based on experimental data obtained in rats obviously did not overestimate the cancer risk for the general population. Furthermore, our results might indicate that the dose-response curve for acrylamide is not linear. This would be in line with the results of animal experiments on rodents.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15729833     DOI: 10.1078/1438-4639-00324

Source DB:  PubMed          Journal:  Int J Hyg Environ Health        ISSN: 1438-4639            Impact factor:   5.840


  16 in total

1.  Biological monitoring for occupational acrylamide exposure from acrylamide production workers.

Authors:  Yu-Fang Huang; Kuen-Yuh Wu; Saou-Hsing Liou; Shi-Nian Uang; Chu-Chih Chen; Wei-Chung Shih; Shih-Chuan Lee; Chih-Chun Jean Huang; Mei-Lien Chen
Journal:  Int Arch Occup Environ Health       Date:  2010-07-02       Impact factor: 3.015

2.  Acrylamide hemoglobin adduct levels and ovarian cancer risk: a nested case-control study.

Authors:  Jing Xie; Kathryn L Terry; Elizabeth M Poole; Kathryn M Wilson; Bernard A Rosner; Walter C Willett; Hubert W Vesper; Shelley S Tworoger
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-02-15       Impact factor: 4.254

3.  Validation of a food frequency questionnaire measurement of dietary acrylamide intake using hemoglobin adducts of acrylamide and glycidamide.

Authors:  Kathryn M Wilson; Hubert W Vesper; Paula Tocco; Laura Sampson; Johan Rosén; Karl-Erik Hellenäs; Margareta Törnqvist; Walter C Willett
Journal:  Cancer Causes Control       Date:  2008-10-15       Impact factor: 2.506

4.  Exposure of the U.S. population to acrylamide in the National Health and Nutrition Examination Survey 2003-2004.

Authors:  Hubert W Vesper; Samuel P Caudill; John D Osterloh; Tunde Meyers; Deanna Scott; Gary L Myers
Journal:  Environ Health Perspect       Date:  2010-02       Impact factor: 9.031

Review 5.  Dietary acrylamide and human cancer: a systematic review of literature.

Authors:  Mandeep K Virk-Baker; Tim R Nagy; Stephen Barnes; John Groopman
Journal:  Nutr Cancer       Date:  2014-05-29       Impact factor: 2.900

6.  Associations between dietary acrylamide intake and plasma sex hormone levels.

Authors:  Janneke G Hogervorst; Renee T Fortner; Lorelei A Mucci; Shelley S Tworoger; A Heather Eliassen; Susan E Hankinson; Kathryn M Wilson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-08-27       Impact factor: 4.254

7.  Dietary acrylamide intake and the risk of lymphatic malignancies: the Netherlands Cohort Study on diet and cancer.

Authors:  Mathilda L Bongers; Janneke G F Hogervorst; Leo J Schouten; R Alexandra Goldbohm; Harry C Schouten; Piet A van den Brandt
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

Review 8.  Exposure assessment of process-related contaminants in food by biomarker monitoring.

Authors:  Ivonne M C M Rietjens; P Dussort; Helmut Günther; Paul Hanlon; Hiroshi Honda; Angela Mally; Sue O'Hagan; Gabriele Scholz; Albrecht Seidel; James Swenberg; Justin Teeguarden; Gerhard Eisenbrand
Journal:  Arch Toxicol       Date:  2018-01-04       Impact factor: 5.153

9.  The influence of single nucleotide polymorphisms on the association between dietary acrylamide intake and endometrial cancer risk.

Authors:  Janneke G F Hogervorst; Piet A van den Brandt; Roger W L Godschalk; Frederik-Jan van Schooten; Leo J Schouten
Journal:  Sci Rep       Date:  2016-10-07       Impact factor: 4.379

10.  Dietary Acrylamide Intake and Risk of Lung Cancer: The Japan Public Health Center Based Prospective Study.

Authors:  Rong Liu; Ling Zha; Tomotaka Sobue; Tetsuhisa Kitamura; Junko Ishihara; Ayaka Kotemori; Sayaka Ikeda; Norie Sawada; Motoki Iwasaki; Shoichiro Tsugane
Journal:  Nutrients       Date:  2020-08-12       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.